Menu
Recruiting NCT05696561

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects With Open-Angle Glaucoma

No phase Interventional OAG - Open-Angle Glaucoma

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: Canaloplasty Device.
Who it may be relevant to
Registry conditions: OAG - Open-Angle Glaucoma. Basic parameters: from 22 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Chile, Costa Rica, Honduras
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Official title

A Prospective, Multicenter, First in Human Clinical Trial to Evaluate the Safety and Effectiveness of the DF12 CANALOPLASTY AND TRABECULOTOMY SURGICAL SYSTEM in Subjects With Open-Angle Glaucoma Undergoing Cataract Surgery

Overview

Clinical Trial to Evaluate the Safety and Effectiveness of a Canaloplasty Device in Subjects with Open-Angle Glaucoma

Interventions

  • Device Canaloplasty Device
    Canaloplasty

Primary outcome measures

  • IOP change [Time frame: Month12]
Secondary outcome measures (2)
  • IOP [Time frame: Month12]
  • IOP meds [Time frame: Month12]

Eligibility criteria

Inclusion criteria

  • Subjects qualifying for cataract surgery
  • Subjects with diagnosis of open-angle glaucoma in at least one eye with unmedicated IOP of 22-34 mmHg.

Exclusion criteria

1\. Patients who cannot be washed-out of IOP-lowering medications.

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Allocation
N/A
Model
Single group
Masking
Open label
Primary purpose
Treatment

Study locations

Chile · 1 center
  • Centro de la Vision — Santiago
Costa Rica · 1 center
  • Clínica 20/20 — San José
Honduras · 1 center
  • Centro Oftalmologico Robles — Santa Rosa de Copán

Identifiers

NCT: NCT05696561 · DF12-CL-22-01

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗